scholarly journals Development of methods for standardization of the active substance, namely the model mixture based on decamethoxine and thiotriazoline

2021 ◽  
Vol 23 (5) ◽  
pp. 703-707
Author(s):  
L. I. Kucherenko ◽  
O. O. Chonka ◽  
O. O. Portna
Keyword(s):  
Hydrochloric Acid ◽  
Polyvinyl Alcohol ◽  
Quantitative Determination ◽  
Active Substance ◽  
Model Mixture ◽  
State Enterprise ◽  
Chemical Reagents ◽  
The Creation ◽  
Active Substances

Today, the important problem is the creation of new decamethoxine and thiotriazoline based drugs for the treatment of stomatitis. The aim of the work is to develop a method for quantitative determination of decamethoxine and thiotriazoline in the model mixture (1:25) by spectrophotometry. Materials and methods. Series 6 model mixtures were made at the ratio of decamethoxine and thiotriazoline 1:25. We used certified substances: thiotriazoline series GTT 3460911 (manufacturer: State Enterprise Chemical Reagents Plant, Kharkiv), decamethoxine series № 010915 (manufacturer: LLC “PHARMCHIM”). Optizen POP spectrophotometer, polyvinyl alcohol, hydrochloric acid, and eosin were used. Results. A method for quantitative determination of decamethoxine and thiotriazoline in MS was developed. It was established that the content of active substances in MS is thiotriazoline from 0.5021 to 0.5096, decamethoxine from 0.0207 to 0.0211. Conclusions. A method for quantitative determination of decamethoxine and thiotriazoline in MS has been developed. The method of quantitative determination of decamethoxine and thiotriazoline in MS is reproducible.

scholarly journals Quantitative Determination of Vinpocetine in Dietary Supplements

2016 ◽  
Vol 11 (5) ◽  
pp. 1934578X1601100
Author(s):  
John M. T. French ◽  
Matthew D. King ◽  
Owen M. McDougal
Keyword(s):  
United States ◽  
Quantitative Determination ◽  
Dietary Supplements ◽  
Nootropic Drugs ◽  
Regulatory Policies ◽  
Short And Long Term ◽  
Pharmacologically Active ◽  
Active Substances

Current United States regulatory policies allow for the addition of pharmacologically active substances in dietary supplements if derived from a botanical source. The inclusion of certain nootropic drugs, such as vinpocetine, in dietary supplements has recently come under scrutiny due to the lack of defined dosage parameters and yet unproven short- and long-term benefits and risks to human health. This study quantified the concentration of vinpocetine in several commercially available dietary supplements and found that a highly variable range of 0.6–5.1 mg/serving was present across the tested products, with most products providing no specification of vinpocetine concentrations.

Strandardization of grown and velvet antlers from reindeer. Part I. Quantitative determination of ninhydrin-active substances in powdered reindeer antlers

1997 ◽  
Vol 31 (4) ◽  
pp. 215-217
Author(s):  
V. P. Pakhomov ◽  
T. V. Maksimova ◽  
I. N. Nikulina ◽  
V. V. Tsygankov ◽  
L. V. Khromova
Keyword(s):  
Quantitative Determination ◽  
Active Substances

THE DETERMINATION OF ZIRCONIUM WITH BENZOYLPHENYLHYDROXYLAMINE

1960 ◽  
Vol 38 (12) ◽  
pp. 2488-2492 ◽  
Author(s):  
D. E. Ryan
Keyword(s):  
Hydrochloric Acid ◽  
Quantitative Determination ◽  
Sulphuric Acid ◽  
Rare Earths ◽  
Acid Solutions ◽  
Constant Composition ◽  
Hydrochloric Acid Solutions

Zirconium is completely precipitated by benzoylphenylhydroxylamine from 0.5 N acid solutions. The complex formed in sulphuric acid solutions has a constant composition, Zr(C13H10O2N)4, and is used for the direct weighing of zirconium; the factor is 0.0970. The product precipitated from hydrochloric acid solutions must be ignited to the oxide. The reaction is sensitive, 1 p.p.m. of zirconium being detectable, and quantitative determination of 0.2 mg is possible. Thorium and the rare earths do not interfere.

scholarly journals The Quantitative Determination of Carbonyl Groups of Polyvinyl Alcohol

1958 ◽  
Vol 15 (156) ◽  
pp. 249-254 ◽  
Author(s):  
Kiyokazu Imai ◽  
Yuziro Kazusa
Keyword(s):  
Polyvinyl Alcohol ◽  
Quantitative Determination ◽  
Carbonyl Groups

scholarly journals Development of UV-spectrophotometry Method of the Quantitative Determination of a New Substance Quinazoline-4(3h)-on Derivate

2020 ◽  
Vol 9 (1) ◽  
pp. 30-34
Author(s):  
E. S. Mishchenko ◽  
A. D. Lazaryan ◽  
T. T. Lihota
Keyword(s):  
Quantitative Determination ◽  
Active Substance ◽  
Research Work ◽  
Biologically Active ◽  
Uv Spectrophotometry ◽  
Pharmacological Effects ◽  
Specific Absorption ◽  
Biologically Active Substance ◽  
Effective Remedy

Introduction. The aim idea of this research article is a development of the quantitative determination of a biologically active substance quinazolin4(3H)-on derivate with laboratory cypher «VMA-10-182, by UV-spectrophotometry with followed validation. The substance is an effective remedy that combines several pharmacological effects, like an antidepressant, anxiolytic and nootropic. As a result of preclinical trials, the research compound has proven to be an effective remedy in the fight and prevention of acute cerebrovascular accident (stroke). The substance realized pharmacological effects by stimulating the production of nitric oxide by the endothelial cells of the brain. As aresult of stimulating is a vasodilation of the vessels and improvement of blood flow in the ischemic part of the vessels occur. Therefore, for introducing the biologically active substance into medical practice we need to develop ways to control the quality of substance.Aim. The objective of this research work is to develop a method of the quantitative determination of a biologically active substance, derivative quinazolin-4(3H)-on (laboratory sypher – VMA-10-18), by method of UV spectrophotometry. The results of the research work were validated.Materials and methods. In this research we used a substance VMA-10-18 wich was previously purified from the initial and intermediate products of the synthesis. This substance is a white crystalline powder, odorless, hygroscopic.Results and discussion. The quantitative content of the active substance derived quinazolin-4(3H)-on has been determined. The specific absorption rate was calculated, followed by statistical processing of the results. The validation was carried out according to the «Specificity», «Linearity», «Accuracy», «Repeatability». The results indicate the effectiveness of the developed methodology and experimental reproducibility.Conclusion. Researches of physicochemical properties show al us use 95 % ethanol as a solvent. As a result we developed a method for the quantitative determination of the substance which can be proposed for inclusion in the normative documents. The quantitative determination of the active substance in the test substance was established, and the specific absorption index was calculated. All information are statistically processed and meet the requirements of regulatory documentation.

scholarly journals The Oxidative Derivatization Method For The Spectrofluorimetric Determination Of Periciazine In Pharmaceutical Preparations

2020 ◽  
Vol 15 (1) ◽  
pp. 21-26
Author(s):  
M.Ye. Blazheyevskiy ◽  
Yu.V. Scrypynets ◽  
A.V. Yegorova ◽  
V.P. Antonovich
Keyword(s):  
Hydrochloric Acid ◽  
Acid Solution ◽  
Quantitative Determination ◽  
Pharmaceutical Preparations ◽  
Oral Solution ◽  
Calibration Plot ◽  
Highly Sensitive ◽  
Spectrofluorimetric Determination ◽  
Derivatizing Agent

The oxidative derivatization method for the indirect spectrofluorimetric determination of Periciazine has been presented. Potassium hydrogenperoxymonosulfate (Oxone ®) is proposed as a derivatizing agent for Periciazine, yielding the strongly fluorescent Periciazine sulfoxide. A highly sensitive, simple and rapid method for determination of the Periciazine by fluorescence of its oxidation product with Oxone ® solution in 0.02 M hydrochloric acid solution (λex = 364 nm; λem = 444 nm) has been developed. The calibration plot is linear in concentration range of 0.05 – 4.00 µg mL -1 . LOQ (10S) is 0.05 µg mL -1 . The possibility of quantitative determination of Periciazine in pharmaceutical preparations (Neuleptil ®, 10 mg capsules and Neuleptil ®, a 30 mL 4 % oral (solution) drops) has been shown RSD < 2.2 % (δ < RSD).

Sign in / Sign up

Export Citation Format

Share Document